Table 2.
Sera concentrations of select inflammation-resolving lipid mediators and omega-3 (DHA) and omega-6 (AA) PUFAs quantified by LC-MS/MS.
| Lipids | Urgent | Asymptomatic | P-value |
|---|---|---|---|
| AA (C20:4-n6) | 0.429 ± 0.046 (μM) | 0.257 ± 0.035 (μM) | 0.005 |
| DHA (C22:6-n3) | 0.052 ± 0.007 (μM) | 0.076 ± 0.008 (μM) | 0.025 |
| EPA (C20:5-n3) | 0.045 ± 0.004 (μM) | 0.056 ± 0.004 (μM) | 0.077 |
| RvD1 | 82 ±11 (pM) | 152±17(pM) | 0.001 |
Notes: Results are mean ± SEM, 21 acute patients and 24 asymptomatic patients; μM: micromolar/L serum; pM: picomolar/L serum.